drugset / Trial / NCT00356772
Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate azithromycin ocular conjunctiva concentrations 7 and 14 days after treatment initiation. To assess ocular and systemic tolerance/safety and azithromycin tear concentrations on Day 7
Timeline
- Start
- 2003-02
- Primary completion
- —
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 1.5 % | Topical |
| Subject | Azithromycin | Small molecule | 1 g | Topical |